Vertex Pharmaceuticals (VRTX)

Operating Income Growth

8.36%

Quarterly · Period ending:

VRTX logo

VRTX Operating Income Growth

Year-over-year change vs the same period a year earlier

Latest reported8.36%
VRTX Quarterly Operating Income YoY % (60.00% → 8.36%)
High-resolution chart · PNG

VRTX operating income growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Operating Income Growth — Quarterly
Period endingOperating Income Growth
-284.5959%
17.0573%
-785.7619%
-9.1511%
190.8846%
9.0147%
117.0732%
-561.9048%
-8.3333%
-65.8537%
-89.2308%
63.1579%
-700%
-119.6429%
-18.1818%
22.973%
85.5422%
34.8837%
-139.1304%
7.5%
19.4175%
-45.7627%
72.619%
-110.5263%
-90.7407%
-84.375%
-197.6744%
-31.0345%
-440%
8.5714%
396.5517%
-11.5385%
56.5217%
-66.6667%
-70.5882%
-85.7143%
-76.9231%
-362.5%
70.6897%
-333.3333%
-316.6667%
60%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.